Bilde av Berge, Gerd
Bilde av Berge, Gerd
Institutt for medisinsk biologi gerd.berge@uit.no +4777644648 Her finner du meg

Gerd Berge


Førsteamanuensis

Stillingsbeskrivelse

Førsteamanuensis og studieprogramleder for master i biomedisin

Mine interesser er kreftforskning, utvikle nye metoder for behandle kreft, og økt livskvalitet hos pasienter.

Som underviser er jeg opptatt av at studentene må ta ansvar for egen læring, og jobber mye med trygghet, mestring og relasjoner for å fremme motivasjon for læring. Dette arbeidet har også resultert i tildeling av Undervisningsprisen ved Helsefak i 2022. 

 


  • Susannah von Hofsten, Manuel K Langer, Katja Korelin, Synnøve Norvoll Magnussen, Dominik Ausbacher, Trude Anderssen m.fl.:
    Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines
    Frontiers in Pharmacology 30. mars 2023 ARKIV / DOI
  • Tina Coucheron, Malgorzata Uhrynowska, Katarzyna Guz, Agnieszka Orzińska, Marzena Debska, Agnieszka Gierszon m.fl.:
    What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies – New insights from a large prospective screening study in Poland
    Journal of Reproductive Immunology 2023 ARKIV / DOI
  • Eirik André Lindeløff Rustad, Susannah von Hofsten, Robin Kumar, Eirik Abrahamsen Lænsman, Gerd Berge, Natasa Skalko-Basnet :
    The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells
    Pharmaceutics 2022 ARKIV / DOI
  • Susannah von Hofsten, Marianne Hagensen Paulsen, Synnøve Magnussen, Dominik Ausbacher, Mathias Kranz, Annette Bayer m.fl.:
    The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines
    Scientific Reports 2022 ARKIV / DOI
  • Ketil Andre Camilio, gerd Berge, Chandra Sekhar Ravuri, Øystein Rekdal, Baldur Sveinbjørnsson :
    Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
    Cancer Immunology and Immunotherapy 2014 ARKIV / DOI
  • Gerd Berge, Liv Tone Eliassen, Ketil Andre Camilio, Kristian Bartnes, Baldur Sveinbjørnsson, Øystein Rekdal :
    Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide
    Cancer Immunology and Immunotherapy 2010 DOI
  • Liv Tone Eliassen, Gerd Berge, Arild Leknessund, Mari Wikman, inger Lindin, Cecilie Løkke m.fl.:
    The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo
    International Journal of Cancer 2006
  • liv tone Eliassen, Bengt Erik Haug, Gerd Berge, Øystein Rekdal :
    Enhanced antitumor activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications
    Journal of Peptide Science 2003
  • liv tone Eliassen, gerd Berge, Baldur Sveinbjørnsson, John Sigurd Svendsen, Lars H. Vorland, Øystein Rekdal :
    Evidence for a direct antitumor mechanism of action of bovine lactoferricin
    Anticancer Research 2002
  • Synnøve Magnussen, Gerd Berge, Ruth Schwienbacher, Anna Maria Wirsing, Elin Synnøve Hadler-Olsen :
    The spatiotemporal immune profile during mouse oral carcinogenesis
    Molecular Oncology 2023 DOI
  • Ruth Schwienbacher, Anna Engan Aamodt, Anna Maria Wirsing, Gerd Berge, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    The spatiotemporal immune profile during mouse oral carcinogenesis - high-endothelial venules develop during early stages - and accumulate in late-stage disease
    2023
  • Ruth Schwienbacher, Anna Engan Aamodt, Anna Maria Wirsing, Gerd Berge, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    The spatiotemporal immune profile during mouse oral carcinogenesis - high-endothelial venules develop during early stages - and accumulate in late-stage disease
    2023
  • May-Britt Five, gerd Berge, Susannah von Hofsten, Kjersti Sellæg :
    Medisiner fra havet
    2023
  • Eirik André Lindeløff Rustad, Stine Figenschau, gerd Berge, Natasa Skalko Basnet :
    Role of liposomal PEGylation on protein corona formation and cellular uptake mechanisms
    2023
  • Kjersti Sellæg, Ruth Schwienbacher, Anna Maria Wirsing, Anna Engan Aamodt, Elin Synnøve Hadler-Olsen, Gerd Berge m.fl.:
    The spatiotemporal immune profile during mouse oral carcinogenesis
    2023
  • Susannah von Hofsten, Marianne Hagensen Paulsen, Manuel K Langer, Synnøve Norvoll Magnussen, Dominik Ausbacher, Annette Bayer m.fl.:
    A Compound Inspired by Arctic Marine Animals Kills Cancer Cells in vitro and in vivo
    2022
  • Susannah von Hofsten, Synnøve Norvoll Magnussen, Dominik Ausbacher, Marianne Hagensen Paulsen, Annette Bayer, Morten B. Strøm m.fl.:
    The Marine Natural Product Mimic MHP88 Shows Anticancer Activity and has the Potential to Cause Immunogenic Cell Death
    2020 ARKIV
  • gerd Berge :
    Kreftcellejakten
    2019
  • Kristel Berg, gerd Berge, inger Lindin, Ketil Andre Camilio, I Chapman, O Rekdal m.fl.:
    Protection against murine A20 B-cell lymphoma tumour re-growth can be passively transferred to untreated naive mice via splenocytes from donors previously treated with LTX-315
    European Journal of Cancer 2009
  • gerd Berge :
    In vivo studies of antitumor peptides
    2006
  • Klara Stensvåg, Tor Haug, Gerd Berge, Guro Strandskog, Terje Vasskog, Erling Sandsdalen m.fl.:
    Antibacterial peptides in spider crab (Hyas araneus)
    2003

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →


    Forskningsinteresser

    Tumor immunologi

    Kreftvaksiner

    Utvikling av legemidler ved kreftbehandling 

    Undervisning

    Emneleder:

    MBI-3012: Advanced methods in experimental biomedicine, 30 stp.

    MBI-3911: Masterthesis in Biomedicine, 60stp.

    MBI-2013: Immonologi, farmakologi, epigenetikk og micriobiologi, 7 stp.

    Underviser:

    Grunnleggende kjemi (TPL-1004Biomedisinske basalfag)

    Integrert metabolisme (ERN-2013 Micronutrients), Innovasjon for masterstudenter (MBI-3012), Tumor immunologi og immunterapi (MBI-3004 The biology of cancer, MBI-2004 Immunology), In vivo/in vitro metoder (ERN-3004 Epidemologi, statistikk og forskningsmetoder)

     

     


    Medlem i forskningsgruppe